Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancerJuly 30, 2026
General New OpenABE gene editor improves editing efficiency by up to 36 timesBy Healthcare Propulsion StaffJuly 30, 20260 A joint research team led by Professor Daesik Kim (Department of Medicine, Sungkyunkwan University), along with Professor Yong-Sub Kim (University…
